How We Can Support the Drug Development Pipeline

Target identification and validation are bottlenecks in drug development.
Accurate and reliable automated methods need to be employed, supported by comprehensive bioinformatics to analyse all the data generated in the search for the next drug or disease target.

Source BioScience provides whole genome expression analysis using the Illumina next generation sequencing platform together with assays against a comprehensive range of known disease-related genes. MicroRNA expression profiling, Affymetrix microarray and ABI SNP analysis is also offered. Source BioScience is an approved provider for all of these services.

Together with experienced staff who worked on the human genome project, Source BioScience offers the expertise and bioinformatics capabilities to identify potential targets for new therapeutics and potential diagnostic indicators for disease. Using these capabilities, we can provide comprehensive data to support development studies, saving our clients time and money.